Indoco Remedies (BOM:532612) FCF Margin % : 0.00% (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Indoco Remedies's Free Cash Flow for the three months ended in Sep. 2024 was ₹0 Mil. Indoco Remedies's Revenue for the three months ended in Sep. 2024 was ₹4,307 Mil. Therefore, Indoco Remedies's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, Indoco Remedies's current FCF Yield % is -8.46%.

The historical rank and industry rank for Indoco Remedies's FCF Margin % or its related term are showing as below:

BOM:532612' s FCF Margin % Range Over the Past 10 Years
Min: -15.44 Med: 0.94 Max: 5.96
Current: -15.44

During the past 13 years, the highest FCF Margin % of Indoco Remedies was 5.96%. The lowest was -15.44%. And the median was 0.94%.

BOM:532612's FCF Margin % is ranked worse than
76.06% of 994 companies
in the Drug Manufacturers industry
Industry Median: 0.9 vs BOM:532612: -15.44

Indoco Remedies FCF Margin % Historical Data

The historical data trend for Indoco Remedies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies FCF Margin % Chart

Indoco Remedies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

5.96

0.44

3.23

-1.73

-15.13

Indoco Remedies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Indoco Remedies's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Indoco Remedies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indoco Remedies's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indoco Remedies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Indoco Remedies's FCF Margin % falls into.

Indoco Remedies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Indoco Remedies's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	-2706.049	/	17882.155
	=	-15.13 %

Indoco Remedies's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	0	/	4306.6
	=	0.00 %

Indoco Remedies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoco Remedies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » FCF Margin %

Traded in Other Exchanges

INDOCO:India

Address

166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098

Website

https://www.indoco.com

Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines